Epstein David R
Director
Track Record
Past 90 daysTotal Buys
13
Avg Return (1M)
-26.3%
Rating
5/100
Latest Insider Transactions
Showing 10 of 19 transactions (past 365 days)
| 2026-11-19 | 2026-11-17 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $5.57 | $27,850 |
| 2026-11-16 | 2026-11-13 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $5.75 | $28,750 |
| 2026-11-16 | 2026-11-13 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $5.99 | $29,950 |
| 2026-11-16 | 2026-11-13 | AGMB AgomAb Therapeutics NV | Director | Purchase | 4,960 | $6.02 | $29,859 |
| 2026-11-16 | 2026-11-13 | AGMB AgomAb Therapeutics NV | Director | Purchase | 20 | $6.00 | $120 |
| 2026-11-06 | 2026-11-05 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $6.91 | $34,550 |
| 2026-11-06 | 2026-11-05 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $6.98 | $34,900 |
| 2026-11-06 | 2026-11-05 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $6.81 | $34,050 |
| 2026-11-04 | 2026-11-02 | TEM Tempus AI, Inc. | Director | Sale | 370 | $74.29 | $27,487 |
| 2026-10-22 | 2026-10-21 | AGMB AgomAb Therapeutics NV | Director | Purchase | 5,000 | $8.90 | $44,500 |
AGMB
Director
Purchase
$27.9K
5,000 shares @ $5.57
Filed 2026-11-19Trade 2026-11-17
AgomAb Therapeutics NVAGMB
Director
Purchase
$28.8K
5,000 shares @ $5.75
Filed 2026-11-16Trade 2026-11-13
AgomAb Therapeutics NVAGMB
Director
Purchase
$29.9K
5,000 shares @ $5.99
Filed 2026-11-16Trade 2026-11-13
AgomAb Therapeutics NVAGMB
Director
Purchase
$29.9K
4,960 shares @ $6.02
Filed 2026-11-16Trade 2026-11-13
AgomAb Therapeutics NVAGMB
Director
Purchase
$34.5K
5,000 shares @ $6.91
Filed 2026-11-06Trade 2026-11-05
AgomAb Therapeutics NVAGMB
Director
Purchase
$34.9K
5,000 shares @ $6.98
Filed 2026-11-06Trade 2026-11-05
AgomAb Therapeutics NVAGMB
Director
Purchase
$44.5K
5,000 shares @ $8.90
Filed 2026-10-22Trade 2026-10-21
AgomAb Therapeutics NVWant to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.